Bare Financial Services’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCRX
Bare Financial Services's PCRX Position: Q3 2026 in Review
Bare Financial Services held its Pacira BioSciences (PCRX) position steady in Q3 2026 at 257 shares worth $6.44K. The position accounts for ﹤0.01% of the portfolio, ranked #807.
Bare Financial Services first reported a position in PCRX in Q1 2026 and has held it in 3 quarters since. The position peaked at $6.52K in Q2 2026. 258 funds tracked by Wall St. Rank hold PCRX as of Q3 2026.
- Bare Financial Services held 257 shares of Pacira BioSciences worth $6.44K as of Q3 2026.
- Bare Financial Services left its Pacira BioSciences share count unchanged in Q3 2026.
- Pacira BioSciences made up ﹤0.01% of Bare Financial Services's portfolio in Q3 2026, its #807 holding.
- Bare Financial Services first reported a position in Pacira BioSciences in Q1 2026 and has held it in 3 quarters since.
- Bare Financial Services's Pacira BioSciences position peaked at $6.52K in Q2 2026.
- 258 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2026.
Based on Bare Financial Services's 13F filing for Q3 2026, filed 4 Nov 2026.